Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury
Lumbrokinase is used as an oral supplement to support and maintain healthy cardiovascular function, and to treat cardiovascular diseases in clinical for more than 10 years. Up until now, the mechanism of the cardioprotective effects of post-ischemic treatment with lumbrokinase has remained unclear....
Saved in:
Main Authors: | Yi-Hsin Wang (Author), Shun-An Li (Author), Chao-Hsin Huang (Author), Hsing-Hui Su (Author), Yi-Hung Chen (Author), Jinghua T. Chang (Author), Shiang-Suo Huang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Paeonol Protects Against Myocardial Ischemia/Reperfusion-Induced Injury by Mediating Apoptosis and Autophagy Crosstalk
by: Chin-Feng Tsai, et al.
Published: (2021) -
AMPK/SIRT1 Pathway is Involved in Arctigenin-Mediated Protective Effects Against Myocardial Ischemia-Reperfusion Injury
by: Cheng-Yin Liu, et al.
Published: (2021) -
Verapamil Alleviates Myocardial Ischemia/Reperfusion Injury by Attenuating Oxidative Stress via Activation of SIRT1
by: Mi Bao, et al.
Published: (2022) -
Dexmedetomidine postconditioning attenuates myocardial ischemia/reperfusion injury by activating the Nrf2/Sirt3/SOD2 signaling pathway in the rats
by: Bin Hu, et al.
Published: (2023) -
SIRT1 is a regulator of autophagy: Implications for the progression and treatment of myocardial ischemia-reperfusion
by: Xiaoqing Ding, et al.
Published: (2024)